Literature DB >> 11290390

Fibrillary beta-amyloid deposits are closely associated with atrophic nitric oxide synthase (NOS)-expressing neurons but do not upregulate the inducible NOS in transgenic Tg2576 mouse brain with Alzheimer pathology.

M Hartlage-Rübsamen1, J Apelt, R Schliebs.   

Abstract

Transgenic mice (Tg2576) that express the Swedish double mutation of human amyloid precursor protein and develop Alzheimer-like beta-amyloid deposits in the aged brain, were used to study the effect of beta-amyloid deposition on expression of both neuronal (nNOS) and inducible nitric oxide synthase (iNOS) in cells surrounding beta-amyloid plaques. Nicotinamide adenine dinucleotide phosphate-diaphorase histochemistry and double immunofluorescent labeling revealed that most of the fibrillary, thioflavine-S-positive cortical beta-amyloid deposits in 13-, 17-, and 21-month-old transgenic animals were closely associated with dystrophic nNOS-positive neurons, while nNOS-bearing neurons located more distal to plaques appeared to be unaffected. There was no significant expression of iNOS in transgenic mouse brain. The data suggest enhanced vulnerability of nNOS-containing neocortical neurons to beta-amyloid toxicity. Alternatively, expression of nNOS may also be a response to plaque-mediated damage of neurons, consistent with a neuroprotective role of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11290390     DOI: 10.1016/s0304-3940(01)01652-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Differences Between Tg2576 and Wild Type Mice in the NMDA Receptor-Nitric Oxide Pathway After Prolonged Application of a Diet High in Advanced Glycation End Products.

Authors:  Zdena Kristofikova; Jan Ricny; Jana Sirova; Daniela Ripova; Irit Lubitz; Michal Schnaider-Beeri
Journal:  Neurochem Res       Date:  2015-07-19       Impact factor: 3.996

2.  NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.

Authors:  C A Colton; M P Vitek; D A Wink; Q Xu; V Cantillana; M L Previti; W E Van Nostrand; J B Weinberg; B Weinberg; H Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

3.  Metallothionein-3 and neuronal nitric oxide synthase levels in brains from the Tg2576 mouse model of Alzheimer's disease.

Authors:  Bruce L Martin; Abigail M Tokheim; Patrick T McCarthy; Brendan S Doms; Andrew A Davis; Ian M Armitage
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

4.  Altered Blood and Brain Expression of Inflammation and Redox Genes in Alzheimer's Disease, Common to APPV717I × TAUP301L Mice and Patients.

Authors:  Catalina Anca Cucos; Elena Milanesi; Maria Dobre; Ioana Andreea Musat; Gina Manda; Antonio Cuadrado
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

5.  Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.

Authors:  Natalia A Stefanova; Kseniya Yi Maksimova; Ekaterina A Rudnitskaya; Natalia A Muraleva; Nataliya G Kolosova
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

6.  Nitrosative Stress in the Frontal Cortex From Dogs With Canine Cognitive Dysfunction.

Authors:  Sonja Prpar Mihevc; Maja Zakošek Pipan; Malan Štrbenc; Boris Rogelj; Gregor Majdič
Journal:  Front Vet Sci       Date:  2020-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.